oxycodone and Pain, Breakthrough

oxycodone has been researched along with Pain, Breakthrough in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (85.71)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Patel, KV; Sahni, S; Taylor, LF1
Evans, T; Nicholas, TA; Sutton, AV; Wysong, A1
Amato, F; Ceniti, S; Consoletti, L; Magaldi, D; Mameli, S; Marcassa, C; Notaro, P; Palmieri, V; Pisanu, GM; Vellucci, R1
Coma, J; De Sanctis, V; Estivill, P; Ferreras, J; Folch, J; Fuentes, J; Guitart, J; Jiménez, AJ; Moya, J; Rodelas, F; Salazar, R; Sanz, A; Tomás, A; Vargas, MI1
Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S1
Alarcón, MDL; Cabezón-Gutiérrez, L; Estévez, FV; Jiménez-López, AJ; Martín-Arroyo, JMT; Padrós, MC; Rebollo, MA; Sanz-Yagüe, A1
Earl, CQ; Narayana, A; Slevin, KA; Webster, LR; Yang, R1
Narayana, A; Passik, SD; Yang, R1
Carroll, E; Conroy, L; Curran, HV; Jones, L; Kamboj, SK; Tookman, A1
Bertulli, R; Bossi, P; Granata, R; Saita, L1
Gajria, KL; Harshaw, Q; Katz, NP; Shillington, AC; Stephenson, JJ1
Fang, WX; Li, F; Sima, L; Wu, XM1
Alvarez-Jiménez, P; Núñez-Olarte, JM1
Davis, MP1

Reviews

1 review(s) available for oxycodone and Pain, Breakthrough

ArticleYear
[Opioid switch and change of route of administration in cancer patients treated by morphine].
    Bulletin du cancer, 2018, Volume: 105, Issue:11

    Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol

2018

Trials

5 trial(s) available for oxycodone and Pain, Breakthrough

ArticleYear
High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Cancer Pain; Chronic Pain; Constipation; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Laxatives; Male; Middle Aged; Naloxone; Neoplasms; Oxycodone; Pain Management; Pain Measurement; Quality of Life

2017
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase
    Pain medicine (Malden, Mass.), 2013, Volume: 14, Issue:9

    Topics: Administration, Buccal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Oxycodone; Pain Management; Patient Satisfaction; Treatment Outcome; Young Adult

2013
Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
    Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:8

    Topics: Administration, Buccal; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Over Studies; Dosage Forms; Double-Blind Method; Female; Fentanyl; Humans; Male; Middle Aged; Opioid-Related Disorders; Oxycodone; Tablets

2014
Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.
    European journal of pain (London, England), 2014, Volume: 18, Issue:10

    Topics: Affect; Aged; Analgesics, Opioid; Breakthrough Pain; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Memory; Mental Recall; Middle Aged; Morphine; Neoplasms; Neuropsychological Tests; Oxycodone; Pain

2014
Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:1

    Topics: Acetaminophen; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Double-Blind Method; Drug Combinations; Female; Fentanyl; Humans; Male; Middle Aged; Morphine; Oxycodone; Pain; Pain Measurement; Patient Satisfaction; Quality of Life; Treatment Outcome

2012

Other Studies

8 other study(ies) available for oxycodone and Pain, Breakthrough

ArticleYear
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.
    Journal of osteopathic medicine, 2023, 01-01, Volume: 123, Issue:1

    Topics: Acetaminophen; Analgesics, Opioid; Animals; Breakthrough Pain; Buprenorphine; Cattle; Chronic Pain; Female; Humans; Oxycodone; Quality of Life

2023
How We Do It: Postoperative Pain Control in Mohs Micrographic Surgery.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 02-01, Volume: 47, Issue:2

    Topics: Acetaminophen; Aged; Analgesics; Anesthesia, Local; Anesthetics, Local; Breakthrough Pain; Celecoxib; Epinephrine; Humans; Lidocaine; Mohs Surgery; Oxycodone; Pain Management; Pain, Postoperative; Pregabalin; Ropivacaine; Vasoconstrictor Agents

2021
Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication.
    Drugs in R&D, 2018, Volume: 18, Issue:2

    Topics: Administration, Sublingual; Aged; Analgesics, Opioid; Breakthrough Pain; Drug Combinations; Drug Therapy, Combination; Female; Fentanyl; Humans; Male; Naloxone; Neoplasm Staging; Neoplasms; Oxycodone; Pain Management; Quality of Life; Treatment Outcome

2018
Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
    Journal of geriatric oncology, 2019, Volume: 10, Issue:4

    Topics: Administration, Mucosal; Aged; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Central Nervous System Depressants; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Decision Making, Shared; Delphi Technique; Drug Interactions; Fentanyl; Frailty; Geriatric Assessment; Geriatrics; Humans; Medical Oncology; Morphine; Oxycodone; Pain Management; Pain Measurement; Palliative Medicine; Patient Care Team; Practice Guidelines as Topic

2019
Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse.
    Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:5

    Topics: Analgesics, Opioid; Breakthrough Pain; Chemoradiotherapy; Coma; Fentanyl; Gastrointestinal Stromal Tumors; Humans; Male; Nasopharyngeal Neoplasms; Opioid-Related Disorders; Oxycodone; Palliative Care; Tramadol; Young Adult

2014
Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
    Postgraduate medicine, 2017, Volume: 129, Issue:1

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Cross-Sectional Studies; Female; Health Surveys; Humans; Hydrocodone; Independent Living; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Quality of Life; Surveys and Questionnaires; United States

2017
Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
    Journal of pain and symptom management, 2011, Volume: 42, Issue:6

    Topics: Adult; Analgesics, Opioid; Bone Neoplasms; Breakthrough Pain; Fatal Outcome; Female; Fentanyl; Humans; Middle Aged; Neoplasms; Opioid-Related Disorders; Ovarian Neoplasms; Oxycodone; Terminal Care

2011
Are there cost benefits to fentanyl for breakthrough pain?
    Journal of pain and symptom management, 2012, Volume: 44, Issue:3

    Topics: Administration, Intranasal; Analgesics, Opioid; Breakthrough Pain; Cost-Benefit Analysis; Fentanyl; Humans; Oxycodone; Risk Reduction Behavior

2012